Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han-Mo Yang

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
JAMA Cardiology|March 9, 2022
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS TrialDoyeon Hwang, Young-Hyo Lim, Kyung Woo Park, et al.
Journal of the American Heart Association|February 20, 2026
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents in Complex Percutaneous Coronary Intervention: Post Hoc Analysis of the Stent Arm Registry From the HOST-IDEA Randomized TrialSang-Hyeon Park, Jung-Kyu Han, Seokhun Yang, et al.
JAMA Cardiology|April 12, 2023
Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM TrialTae-Min Rhee, Jang-Whan Bae, Kyung Woo Park, et al.
Circulation. Cardiovascular Interventions|September 22, 2025
Long-Term Impact of Platelet Reactivity and Clinical Risk on Clinical Outcomes in Patients With Coronary Artery Disease: Analysis of the PTRG-DES RegistryJeehoon Kang, Sungjoon Park, Kyung Woo Park, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 30, 2023
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trialKyu-Sun Lee, Keun-Ho Park, Kyung Woo Park, et al.
JACC. Cardiovascular Interventions|September 21, 2013
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen)Kyung Woo Park, Si-Hyuck Kang, Jin Joo Park, et al.
Korean Circulation Journal|October 17, 2017
Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable PolymerHyoung Mo Yang, Kyoung Woo Seo, Junghan Yoon, et al.
Cardiology Journal|February 26, 2021
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registryEun-Seok Shin, Eun Jung Jun, Jung-Kyu Han, et al.
Medicine|June 9, 2021
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymerKyoung-Woo Seo, Hyoung-Mo Yang, Junghan Yoon, et al.
Korean Circulation Journal|June 3, 2022
Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI"You-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
JAMA Cardiology|March 9, 2022
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS TrialDoyeon Hwang, Young-Hyo Lim, Kyung Woo Park, et al.
Journal of the American Heart Association|February 20, 2026
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents in Complex Percutaneous Coronary Intervention: Post Hoc Analysis of the Stent Arm Registry From the HOST-IDEA Randomized TrialSang-Hyeon Park, Jung-Kyu Han, Seokhun Yang, et al.
JAMA Cardiology|April 12, 2023
Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM TrialTae-Min Rhee, Jang-Whan Bae, Kyung Woo Park, et al.
Circulation. Cardiovascular Interventions|September 22, 2025
Long-Term Impact of Platelet Reactivity and Clinical Risk on Clinical Outcomes in Patients With Coronary Artery Disease: Analysis of the PTRG-DES RegistryJeehoon Kang, Sungjoon Park, Kyung Woo Park, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 30, 2023
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trialKyu-Sun Lee, Keun-Ho Park, Kyung Woo Park, et al.
JACC. Cardiovascular Interventions|September 21, 2013
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen)Kyung Woo Park, Si-Hyuck Kang, Jin Joo Park, et al.
Korean Circulation Journal|October 17, 2017
Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable PolymerHyoung Mo Yang, Kyoung Woo Seo, Junghan Yoon, et al.
Cardiology Journal|February 26, 2021
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registryEun-Seok Shin, Eun Jung Jun, Jung-Kyu Han, et al.
Medicine|June 9, 2021
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymerKyoung-Woo Seo, Hyoung-Mo Yang, Junghan Yoon, et al.
Korean Circulation Journal|June 3, 2022
Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI"You-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.
Pageof 20